Vivid-Scientific LLC sold injectable fat-dissolving products online as unapproved new drugs without FDA-approved applications.
What happened
FDA reviewed Vivid-Scientific's website in January 2025 and found it offered LemonBottle Ampoule Solution, Lipo Lab PPC Solution, Neobella Extreme, and Deoxycholic Acid Booster for sale in the United States. FDA said website claims such as “FAT DISSOLVER” and “permanent fat removal” establish that the injectable products are intended as drugs. FDA said no approved applications are in effect for these products, so they are unapproved new drugs.
What FDA found
The products are unapproved new drugs because no FDA-approved application is in effect for them.
Federal Food, Drug, and Cosmetic Act (FD&C Act) sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)Website claims make the products drugs intended to affect the structure or function of the body.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products are not generally recognized as safe and effective for the claimed uses, so they are new drugs.
FD&C Act section 201(p), 21 U.S.C. 321(p)
What FDA wants
FDA asks Vivid-Scientific to notify it in writing within 15 working days of the specific steps taken to correct the violations, including an explanation and related documentation. If corrections cannot be completed in that time, the company must state the reason for delay and when it will finish.
Who should pay attention
- clinics and med spas that buy injectable fat-dissolving products
- online sellers of injectable cosmetic or lipolytic products
- distributors that source unapproved injectable drug products
This is a summary. Read the original letter on fda.gov.